Tumor Subtype Discrimination
Tumor Subtype Discrimination - Related Videos
02:55
Stereotypes, Prejudice, and Discrimination
0 Views •
2020
Humans are very diverse and although we share many similarities, we also have many differences. The social groups we belong to help form our identities (Tajfel, 1974). These differences may be difficult for some people to reconcile, which may lead to prejudice toward people who are different. Prejudice is a negative attitude and feeling toward an individual based solely on one’s membership in a particular social group (Allport, 1954; Brown, 2010). Prejudice is common against people who are...
06:41
Testing for Odor Discrimination and Habituation in Mice
0 Views •
Cited by 66 •
2015
This manuscript describes a protocol to examine the olfactory system of rodents. The olfactory habituation/dishabituation test will allow investigators to determine whether a mouse habituates to a repeatedly presented odor and whether the mouse demonstrates dishabituation when presented a novel odor.
14:40
Expression Analysis of Mammalian Linker-histone Subtypes
0 Views •
Cited by 22 •
2012
We describe a set of assays to analyze expression levels of H1 linker histones. mRNA of individual H1 genes are quantitatively measured by random primer based reverse transcription followed by real-time PCR, whereas protein quantification of H1 histones is achieved by HPLC analysis.
06:42
Subtype-selective Electroporation of Cortical Interneurons
0 Views •
Cited by 13 •
2014
This procedure shows how to target interneurons in the developing mouse forebrain by means of in utero electroporation. This technique was particularly efficient to achieve selective gene expression in interneuron subtypes destined to the superficial layers of the cortex.
01:25
Price Discrimination under Monopoly
0 Views •
2024
Price discrimination under monopoly refers to the practice where a monopolist charges different prices for the same product or service to different customers or in different markets. This strategy allows the monopolist to capture more consumer surplus, turning it into additional profits. For price discrimination to be effective, three conditions must be met: 1) the firm must have market power, 2) the firm must have the ability to separate markets or customers, and 3) the firm faces different...
FAQs
Tissue morphology may make tumors appear similar even when their gene expression, mutations, protein biomarkers, or other molecular profiles differ. Comparing these feature types reveals biological distinctions that visual examination may not capture. This broader characterization is important because otherwise clinically meaningful differences in prognosis or treatment response could remain hidden.
Statistical and computational classification methods organize measurements from tumor samples and assign them to defined subtype groups. Their value lies in converting complex patterns across morphology and molecular features into reproducible classifications. These assignments help investigators compare samples systematically and connect subtype patterns with prognosis, therapy response, disease mechanisms, or treatment resistance.
Molecular differences can indicate that tumors within one cancer type follow distinct biological pathways or respond differently to treatment. Examining gene expression, mutations, protein biomarkers, and related profiles therefore adds information beyond the shared cancer label. In cancer research, this distinction supports more precise risk assessment and helps explain variable therapeutic outcomes.
Investigators can compare tissue morphology alongside gene expression, mutations, protein biomarkers, and other molecular profiles. Each data type describes a different aspect of the tumor, so examining them provides a broader basis for separating biologically distinct groups. The resulting classifications can be evaluated for relevance to diagnosis, prognosis, treatment response, and disease mechanisms.
Subtype assignments can refine diagnosis by indicating which biological group a tumor most closely matches. They also support risk assessment and therapy selection when defined groups show different prognoses or treatment responses. In this way, the method connects tumor characterization with clinically relevant decisions, while preserving the distinction between tumors that may look alike.
In research, subtype analysis helps investigators study disease mechanisms and treatment resistance, while expanding molecular datasets can sharpen cancer models. It also supports the development of targeted therapies and clinically meaningful biomarkers. These outcomes make subtype classification useful not only for organizing samples, but also for linking biological variation to future therapeutic and diagnostic research.